GlassScriptPhysician profile
Jeremy J Simpler
NPI 1528249554
$5,249.28
in general payments reported to CMS, 2019-2025
30 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,269 · 2020: $342 · 2021: $163 · 2022: $267 · 2023: $317 · 2024: $486 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,226.57 | 2019-2025 | |
| Medical Device Business Services, INC. | $958.94 | 2019 | |
| Organogenesis INC. | $434.20 | 2022-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Davol INC. | $416.78 | 2020-2025 | Phasix Mesh |
| Ethicon US, LLC | $164.43 | 2022-2024 | N/A, Echelon; Endopath, Megadyne |
| Boston Scientific Corporation | $101.61 | 2024 | Axios, Spyglass |
| Vertex Pharmaceuticals Incorporated | $87.19 | 2024-2025 | |
| Medtronic USA, INC. | $86.07 | 2020 | |
| Smith+Nephew, INC. | $84.34 | 2020-2025 | Renasys Touch, Pico 14 |
| Medtronic, INC. | $80.88 | 2021-2024 | Interstim |
| Tela Bio, INC. | $79.80 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $73.47 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $53.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axonics, INC. | $48.87 | 2021-2023 | Axonics |
| Mallinckrodt Hospital Products INC. | $39.23 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $38.23 | 2019 | |
| Tei Biosciences INC | $33.92 | 2019 | |
| Lilly USA, LLC | $29.55 | 2024 | Zepbound |
| Conmed Corporation | $29.16 | 2024 | Airseal |
| Zimmer Biomet Holdings, INC. | $23.16 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.52 | 2021 | |
| Merck Sharp & Dohme LLC | $20.30 | 2023 | Keytruda |
| W. L. Gore & Associates, INC. | $19.07 | 2024 | Gore Propaten Vascular Graft |
| Reprise Biomedical, INC. | $16.57 | 2025 | Miro3d |
| Baxter Healthcare | $15.69 | 2020 | |
| Innovation Technologies INC | $14.99 | 2024 | Irrisept |
| Endo Pharmaceuticals INC. | $14.87 | 2019 | |
| Bioventus LLC | $13.86 | 2022 | |
| Csl Behring | $11.17 | 2019 | |
| Acera Surgical, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Simpler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.